HEMITARTARATO DE RIVASTIGMINA 4,5 MG CAP DURA CT BL AL PLAS TRANS X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1235202590152
  • GGREM 529920110069807
  • Código de barras 7897076922656

O que a fonte publica

Detentor do registro
RANBAXY FARMACÊUTICA LTDA
Princípios ativos
HEMITARTARATO DE RIVASTIGMINA
Embalagem
4,5 MG CAP DURA CT BL AL PLAS TRANS X 30
Regime de dispensação
Tarja Vermelha sob restrição
Tipo de produto
Genérico
Classe terapêutica
N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:529920110069807
{
  "name": "HEMITARTARATO DE RIVASTIGMINA 4,5 MG CAP DURA CT BL AL PLAS TRANS X 30",
  "holder": "RANBAXY FARMACÊUTICA LTDA",
  "stripe": "Tarja Vermelha sob restrição",
  "barcodes": [
    "7897076922656"
  ],
  "confaz87": true,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "529920110069807",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "73.663.650/0001-90",
  "priceRegime": "Regulado",
  "productName": "HEMITARTARATO DE RIVASTIGMINA",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "4,5 MG CAP DURA CT BL AL PLAS TRANS X 30",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha sob restrição",
  "factoryPrices": {
    "icms-0": "186.62",
    "icms-12": "212.07",
    "icms-17": "224.84",
    "icms-18": "227.59",
    "icms-19": "230.40",
    "icms-20": "233.28",
    "icms-21": "236.23",
    "icms-22": "239.26",
    "icms-23": "242.36",
    "icms-17.5": "226.21",
    "icms-19.5": "231.83",
    "icms-20.5": "234.74",
    "icms-22.5": "240.80",
    "icms-12-alc": "209.52",
    "icms-17-alc": "222.15",
    "icms-18-alc": "224.85",
    "icms-19-alc": "227.63",
    "icms-20-alc": "230.48",
    "icms-21-alc": "233.39",
    "icms-22-alc": "236.39",
    "icms-23-alc": "239.46",
    "withoutTaxes": "184.38",
    "icms-17.5-alc": "223.49",
    "icms-19.5-alc": "229.04",
    "icms-20.5-alc": "231.93",
    "icms-22.5-alc": "237.91"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "HEMITARTARATO DE RIVASTIGMINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "257.24",
    "icms-12": "292.32",
    "icms-17": "309.92",
    "icms-18": "313.71",
    "icms-19": "317.58",
    "icms-20": "321.55",
    "icms-21": "325.62",
    "icms-22": "329.79",
    "icms-23": "334.07",
    "icms-17.5": "311.81",
    "icms-19.5": "319.55",
    "icms-20.5": "323.56",
    "icms-22.5": "331.92",
    "icms-12-alc": "289.65",
    "icms-17-alc": "307.11",
    "icms-18-alc": "310.84",
    "icms-19-alc": "314.69",
    "icms-20-alc": "318.63",
    "icms-21-alc": "322.65",
    "icms-22-alc": "326.80",
    "icms-23-alc": "331.04",
    "withoutTaxes": "254.90",
    "icms-17.5-alc": "308.96",
    "icms-19.5-alc": "316.63",
    "icms-20.5-alc": "320.63",
    "icms-22.5-alc": "328.90"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "HEMITARTARATO DE RIVASTIGMINA"
  ],
  "therapeuticClass": "N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1235202590152",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "N7D1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:529920110069807"